- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Number of new drugs launched in the U.S. 2003-2015
Number of new drugs launched in the U.S. 2003-2015
Number of new molecular entities launched in the U.S. from 2003 to 2015
This statistic shows the number of new molecular entities launched in the United States from 2003 to 2015. In 2003, a total of 24 new medicines were launched in the United States, six of them were orphan drugs.
Number of new molecular entities launched in the U.S. from 2003 to 2015
Loading statistic...
| New Mechanism | Orphan | Existing Mechanism | |
|---|---|---|---|
| 2015 | 14 | 15 | 14 |
| 2014 | 7 | 20 | 18 |
| 2013 | 8 | 17 | 11 |
| 2012 | 12 | 8 | 8 |
| 2011 | 11 | 12 | 10 |
| 2010 | 9 | 8 | 9 |
| 2009 | 8 | 7 | 18 |
| 2008 | 7 | 6 | 7 |
| 2007 | 6 | 5 | 7 |
| 2006 | 10 | 9 | 9 |
| 2005 | 11 | 4 | 6 |
| 2004 | 12 | 5 | 3 |
| 2003 | 13 | 6 | 5 |
| New Mechanism | Orphan | Existing Mechanism | |
|---|---|---|---|
| 2015 | 14 | 15 | 14 |
| 2014 | 7 | 20 | 18 |
| 2013 | 8 | 17 | 11 |
| 2012 | 12 | 8 | 8 |
| 2011 | 11 | 12 | 10 |
| 2010 | 9 | 8 | 9 |
| 2009 | 8 | 7 | 18 |
| 2008 | 7 | 6 | 7 |
| 2007 | 6 | 5 | 7 |
| 2006 | 10 | 9 | 9 |
| 2005 | 11 | 4 | 6 |
| 2004 | 12 | 5 | 3 |
| 2003 | 13 | 6 | 5 |
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
This statistic shows the number of new molecular entities launched in the United States from 2003 to 2015. In 2003, a total of 24 new medicines were launched in the United States, six of them were orphan drugs.
Show more- Show sources information
- Show publisher information
- Release date
- April 2016
- Region
- United States
- Survey time period
- 2003 to 2015
- Supplementary notes
-
New Molecular Entity (NME): A novel molecular or biologic
entity or combination where at least one element is novel.
This statistic was assembled from several IMS Health reports.
NME launches in the U.S. by year of launch, regardless of timing of FDA approval.
New mechanism: First product with a new mechanism of action for its FDA approved indication.
Orphan: Drugs with one or more orphan indications approved by FDA at launch.
Existing mechanism: Subsequent products with an existing mechanism of action for an indication. - Open this statistic in...
Source
- Show sources information
- Show publisher information
- Release date
- April 2016
More information
- Region
- United States
- Survey time period
- 2003 to 2015
- Supplementary notes
-
New Molecular Entity (NME): A novel molecular or biologic
entity or combination where at least one element is novel.
This statistic was assembled from several IMS Health reports.
NME launches in the U.S. by year of launch, regardless of timing of FDA approval.
New mechanism: First product with a new mechanism of action for its FDA approved indication.
Orphan: Drugs with one or more orphan indications approved by FDA at launch.
Existing mechanism: Subsequent products with an existing mechanism of action for an indication. - Open this statistic in...
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
U.S. pharmaceutical industry
- 110 page/s
- English
- pptx
- Detailed references
Everything On "U.S. pharmaceutical industry" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation
Statistics on "U.S. pharmaceutical industry"
- Contribution to global pharma
The most important statistics
- Distribution of the total global pharmaceutical market sales from 2014 to 2018, by submarket*World pharmaceutical market distribution by submarket 2014-2018
- Global pharmaceutical sales from 2016 to 2018, by region (in billion U.S. dollars)*World pharmaceutical sales 2016-2018 by region
- Market share of top 10 national pharmaceutical markets worldwide in 2017*Market share of the leading 10 global pharmaceutical markets 2017
- Growth of top 10 national pharmaceutical markets worldwide from 2012 to 2017*Top 10 global pharmaceutical markets: growth 2012-2017
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2017 (in billion U.S. dollars)Top 50 pharmaceutical companies - Rx sales and R&D spending 2017
- Leading countries in global life sciences mergers and acquisitions based on deal number in 2018Leading countries in life sciences sector M&As 2018
- Overview
The most important statistics
- Total nominal spending on medicines in the U.S. from 2002 to 2016 (in billion U.S. dollars)*U.S. total medicine spending 2002-2016
- Top 20 U.S. therapy areas based on drug spending in 2016 (in billion U.S. dollars)Leading therapy areas for U.S. drug spending 2016
- Top 20 prescription drugs based on U.S. sales in 2016 (in billion U.S. dollars)*U.S. top 20 prescribed drugs based on sales 2016
- Top 20 U.S. pharma products by dispensed prescriptions in 2016 (in millions)Top U.S. pharma products by prescriptions 2016
- Channel distribution of U.S. pharmaceutical spending from 2014 to 2016 (in billion U.S. dollars)Pharmaceutical channel distribution by U.S. spending 2014-2016
- U.S. pharmaceutical preparation manufacturing gross output from 1998 to 2016 (in million U.S. dollars)*Pharmaceutical preparation manufacturing gross output 1998-2016
- U.S. biopharmaceutical goods export volume from 2002 to 2017 (in billion U.S. dollars)U.S. biopharmaceutical export volume 2002-2017
- Companies
The most important statistics
- 2018 ranking of the top 10 U.S. biotech and pharmaceutical companies based on revenue (in billion U.S. dollars)*2018 list of top U.S. biotech and pharmaceutical companies based on revenue
- Top 20 pharmaceutical corporations by U.S. revenue in 2016 (in billion U.S. dollars)*Pharmaceutical corporations by U.S. revenue 2016
- Johnson & Johnson's total revenue from 2005 to 2018 (in million U.S. dollars)Johnson & Johnson's total revenue 2005-2018
- Pfizer's total revenue from 2006 to 2018 (in million U.S. dollars)Pfizer's total revenue 2006-2018
- Total revenue of Merck & Co. from 2006 to 2018 (in million U.S. dollars)Merck & Co - total revenue 2006-2018
- Advertising expenditure of selected pharmaceutical companies in the United States in 2015 (in thousand U.S. dollars)Ad spending of pharmaceutical companies in the U.S. 2015
- Top pharmaceutical company penalties in the United States between 2012 and 2015 (in million U.S. dollars)*Highest pharmaceutical company penalties in the U.S. 2012-2015
- Top 10 pharmaceutical companies in Canada in 2016, by revenue (in billion Canadian dollars)Top pharmaceutical companies located in Canada by revenue 2016
- Research and development
The most important statistics
- Research and development expenditure of total U.S. pharmaceutical industry from 1995 to 2017 (in billion U.S. dollars)*Research and development expenditure: U.S. pharmaceutical industry 1995-2017
- Spending of U.S. pharmaceutical industry for research and development as a percentage of total revenues from 1990 to 2017U.S. pharma industry R&D spending as a percent of total revenues 1990-2017
- Number of biopharma medicines in development in the U.S. as of May 2018, by therapeutic category*Pharmaceuticals: biopharma medicines in development 2018 by category
- Cost of developing a drug in the U.S. from the 1970s until today (in million U.S. dollars)*Pharmaceuticals: cost of drug development in the U.S. since 1975
- Number of new molecular entities launched in the U.S. from 2003 to 2015Number of new drugs launched in the U.S. 2003-2015
- Number of FDA approved orphan designations in the United States from 2000 to 2014Number of FDA approved orphan designations in the U.S. 2000-2014
- New medicine brands spending growth in the U.S. from 2011 to 2015 (in billion U.S. dollars)U.S. sales growth of new brand medicines 2011-2015
- Pharmaceutical R&D expenditure per employee compared to other U.S. manufacturing sectors 2000-2014R&D expenditure per employee in U.S. sectors 2000-2014
- Generics
The most important statistics
- Change in branded and generic medication spending in the United States from 2013 to 2017 (in billion U.S. dollars)*Spending change on branded and generic medicines in the U.S. 2013-2017
- Proportion of branded versus generic prescription drug revenues in the United States from 2005 to 2016U.S. brand and generic prescription drug revenue 2005-2016
- Proportion of branded versus generic drug prescriptions dispensed in the United States from 2005 to 2016Branded vs. generic U.S. drug prescriptions dispensed 2005-2016
- Savings through generic drug usage in the United States from 2008 to 2017 (in billion U.S. dollars)Savings through generic drug usage in the U.S. 2008-2017
- Leading drugs going off patent in the U.S. in 2017, by revenue (in million U.S. dollars)*Biggest selling drugs with patent at threat in the U.S. in 2017, by revenue
- Outlook
The most important statistics
- Projected revenue growth rates of the global pharmaceutical industry in the period 2015-2018, by regionForecast of CAGR global pharmaceutical industry by region 2015-2018
- Forecast of global medicine spending distribution in 2020, by region*Global spending on medicines by regional share forecast 2020
- Projected global pharmaceutical sales for 2022, by region (in billion U.S. dollars)*World pharmaceutical sales by region forecast 2022
- Selected top branded biologic drugs in the United States that will go generic between 2016 and 2028, by revenue (in billion U.S. dollars)*Top branded biologic drugs in the U.S. that will go generic by 2028
- Projected top 25 pharmaceutical products by U.S. revenue in 2024 (in million U.S. dollars)Leading U.S. pharmaceutical products by revenue 2024
- Healthcare and pharmaceutical industry digital advertising spending in the United States from 2011 to 2019 (in billion U.S. dollars)Healthcare and pharmaceutical industry digital ad spend in the U.S. 2011-2019
- The consumer's view
The most important statistics
- How is your overall impression of the U.S. pharma industry?U.S. adults impression of the U.S. pharma industry
- How high do you think the pressure on physicians is from the pharma industry to prescribe certain drugs?U.S. adults that believe physicians are under pressure from pharma to prescribe drugs
- How would you rate the U.S. pharma companies concerning the quality of their drugs?U.S. adults impression of the U.S. pharma drug qualities
- How would you rate the U.S. pharma companies concerning their fairness towards patients?U.S. adults impression of the U.S. pharma companies fairness towards patients
- Percentage of Americans who would rate U.S. pharma companies excellent or good in selected features as of 2017U.S. adults who would rate selected pharma features as excellent or good 2017
- Which of these pharma companies do you prefer when buying drugs?Preferred pharma companies by Americans for drug purchase 2017
- Opinion of Americans on U.S. pharmaceutical product quality compared to foreign products as of 2017*Americans on US pharma quality compared to foreign pharma 2017
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Availability of new medicines in selected countries 2013
- Global pharmaceutical product launches by therapy area 2004-2013
- Changes in prescriptions for U.S. young adults
- Changes in prescriptions for older people in the U.S. 2011
- U.S. insured patients' out-of-pocket health spending 2008-2011
- Top therapy spending areas in pharmerging markets 2018
- Medicine spending share globally in 2007,2017 and 2022, by country group
- Medicinal market growth by world region, specialty and traditional 2013-2018
- Reasons for rejected payer retail prescriptions in the U.S. in select classes 2013
- Medicinal market growth worldwide including rebates 2009-2018
- Small molecules facing loss of developed market exclusivity 2011-2020
- Prescription per capita in the United States by age group 2013
- Change in U.S. rate of medicine use by patient age 2013
- Top therapy areas in the U.S. by number of prescriptions 2016
- Total and per capita change in U.S. prescriptions 2004-2013
- Canada: B2B magazine launches 2002-2012, by interest category
- Antibacterials for systemic use: consumption in Estonia 2016
- Domestic demand of surface-active agents Japan 2012-2017
- Italy: monthly value of medicaments exports 2017
- Direct export value of glucose reagent from Taiwan 2008-2017
Studies
- Personalized medicine
- Over-the-counter medicine industry in the United Kingdom
- Pharmaceutical industry in Japan
- Meds Entry Watch 2017
- The Access to Medicine Index 2018
- Pharmaceutical industry in China
- Public Perspectives on Personalized Medicine (May 2018)
- Roland Berger Focus - Regenerative medicine
- Top pharmaceutical drugs
- Meds Entry Watch 2016
- Patented Medicine Prices Review Board - Annual Report 2017
- Prescribing for Diabetes, England 2007/08 to 2017/18
- Prescription Cost Analysis, England 2018
- Value of Personalized Medicine (Spring 2015)
- The Personalized Medicine Report 2017
Statistics on "U.S. pharmaceutical industry"
- Distribution of the total global pharmaceutical market sales from 2014 to 2018, by submarket*
- Global pharmaceutical sales from 2016 to 2018, by region (in billion U.S. dollars)*
- Market share of top 10 national pharmaceutical markets worldwide in 2017*
- Growth of top 10 national pharmaceutical markets worldwide from 2012 to 2017*
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2017 (in billion U.S. dollars)
- Leading countries in global life sciences mergers and acquisitions based on deal number in 2018
- Total nominal spending on medicines in the U.S. from 2002 to 2016 (in billion U.S. dollars)*
- Top 20 U.S. therapy areas based on drug spending in 2016 (in billion U.S. dollars)
- Top 20 prescription drugs based on U.S. sales in 2016 (in billion U.S. dollars)*
- Top 20 U.S. pharma products by dispensed prescriptions in 2016 (in millions)
- Channel distribution of U.S. pharmaceutical spending from 2014 to 2016 (in billion U.S. dollars)
- U.S. pharmaceutical preparation manufacturing gross output from 1998 to 2016 (in million U.S. dollars)*
- U.S. biopharmaceutical goods export volume from 2002 to 2017 (in billion U.S. dollars)
- 2018 ranking of the top 10 U.S. biotech and pharmaceutical companies based on revenue (in billion U.S. dollars)*
- Top 20 pharmaceutical corporations by U.S. revenue in 2016 (in billion U.S. dollars)*
- Johnson & Johnson's total revenue from 2005 to 2018 (in million U.S. dollars)
- Pfizer's total revenue from 2006 to 2018 (in million U.S. dollars)
- Total revenue of Merck & Co. from 2006 to 2018 (in million U.S. dollars)
- Advertising expenditure of selected pharmaceutical companies in the United States in 2015 (in thousand U.S. dollars)
- Top pharmaceutical company penalties in the United States between 2012 and 2015 (in million U.S. dollars)*
- Top 10 pharmaceutical companies in Canada in 2016, by revenue (in billion Canadian dollars)
- Research and development expenditure of total U.S. pharmaceutical industry from 1995 to 2017 (in billion U.S. dollars)*
- Spending of U.S. pharmaceutical industry for research and development as a percentage of total revenues from 1990 to 2017
- Number of biopharma medicines in development in the U.S. as of May 2018, by therapeutic category*
- Cost of developing a drug in the U.S. from the 1970s until today (in million U.S. dollars)*
- Number of new molecular entities launched in the U.S. from 2003 to 2015
- Number of FDA approved orphan designations in the United States from 2000 to 2014
- New medicine brands spending growth in the U.S. from 2011 to 2015 (in billion U.S. dollars)
- Pharmaceutical R&D expenditure per employee compared to other U.S. manufacturing sectors 2000-2014
- Change in branded and generic medication spending in the United States from 2013 to 2017 (in billion U.S. dollars)*
- Proportion of branded versus generic prescription drug revenues in the United States from 2005 to 2016
- Proportion of branded versus generic drug prescriptions dispensed in the United States from 2005 to 2016
- Savings through generic drug usage in the United States from 2008 to 2017 (in billion U.S. dollars)
- Leading drugs going off patent in the U.S. in 2017, by revenue (in million U.S. dollars)*
- Projected revenue growth rates of the global pharmaceutical industry in the period 2015-2018, by region
- Forecast of global medicine spending distribution in 2020, by region*
- Projected global pharmaceutical sales for 2022, by region (in billion U.S. dollars)*
- Selected top branded biologic drugs in the United States that will go generic between 2016 and 2028, by revenue (in billion U.S. dollars)*
- Projected top 25 pharmaceutical products by U.S. revenue in 2024 (in million U.S. dollars)
- Healthcare and pharmaceutical industry digital advertising spending in the United States from 2011 to 2019 (in billion U.S. dollars)
- How is your overall impression of the U.S. pharma industry?
- How high do you think the pressure on physicians is from the pharma industry to prescribe certain drugs?
- How would you rate the U.S. pharma companies concerning the quality of their drugs?
- How would you rate the U.S. pharma companies concerning their fairness towards patients?
- Percentage of Americans who would rate U.S. pharma companies excellent or good in selected features as of 2017
- Which of these pharma companies do you prefer when buying drugs?
- Opinion of Americans on U.S. pharmaceutical product quality compared to foreign products as of 2017*
- Global new molecular entities availability in selected countries in 2013*
- Global pharmaceutical product launches between 2004 and 2013, by therapy area*
- Largest changes in medical prescriptions for young adults in the U.S. in 2011* (per 1,000 population)
- Largest changes in medical prescriptions for older people in the U.S. in 2011 (per 1,000 population)
- Insured patients' out-of-pocket costs in the U.S. from 2008 to 2011 (in billion U.S. dollars)
- Top therapy areas in pharmerging markets in 2018, by spending (in billion U.S. dollars)*
- Global medicine spending distribution in 2007, 2017 and 2022, by country group
- Projected distribution of global medicinal market growth from 2013 to 2018, by region and type of medicine*
- Distribution of reasons for rejected payer retail prescriptions in the United States in 2013
- Global medicinal market growth including rebates from 2009 to 2018 (in billion U.S. dollars)
- Loss through small molecule patent expiries in developed pharmaceutical markets from 2011 to 2020 (in billion U.S. dollars)
- Prescriptions per capita in the U.S. in 2013, by age group*
- Change in rate of medicine use in U.S. in 2013, by patient age*
- Top 20 therapy areas in the United States in 2016, by number of prescriptions (in millions)
- Change in nominal and per capita dispensed prescriptions in United States from 2004 to 2013
- Number of business media magazine launches in Canada from 2002 to 2012, by interest catgory
- Consumption of antibacterials for systemic use in Estonia in 2016 (in DDD per 1,000 inhabitants per day)
- Domestic demand of surface-active agents in Japan from 2012 to 2017 (in 1,000 tons)
- Monthly value of medicaments consisting of mixed or unmixed products exports from Italy January to December 2017 (in U.S. dollars)
- Direct export value of glucose reagent from Taiwan between 2008 and 2017 (in billion New Taiwan dollars)
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Please log in to access our additional functions
Register in seconds and access exclusive features.
Basic Account
|
Instant Access
Premium Account
| ||
|---|---|---|---|
Our services
Click the question mark for further information | Free |
$49 per month* | |
| Basic statistics | |||
| Premium statistics | |||
|
Graph download
| |||
| Download PDF | |||
|
Excel download
| |||
| Register | Purchase now | ||
*Duration: 12 months, billed annually, single license
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.